Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Advances in Therapy
Erschienen in: Advances in Therapy 10/2023

18.07.2023 | Review

Perspectives and Considerations of IABP in the Era of ECMO for Cardiogenic Shock

verfasst von: Zelin Chen, Yuping Gao, Yuanyuan Lin

Erschienen in: Advances in Therapy | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

The development of mechanical circulatory support (MCS) has been rapid, and its use worldwide in patients with cardiogenic shock is increasingly widespread. However, current statistical data and clinical research do not demonstrate its significant improvement in the patient prognosis. This review focuses on the widely used intra-aortic balloon pumps (IABP) and veno-arterial extracorporeal membrane oxygenation (VA-ECMO), analyzing and comparing their characteristics, efficacy, risk of complications, and the current exploration status of left ventricular mechanical unloading. Subsequently, we propose a rational approach to viewing the negative outcomes of current MCS, and look ahead to the future development trends of IABP.
Literatur
1.
Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV. Cardiogenic shock after acute myocardial infarction: a review. JAMA. 2021;326(18):1840–50.PubMedPubMedCentralCrossRef
2.
Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA. 2007;297(17):1892–900.PubMedCrossRef
3.
Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, et al. A standardized and comprehensive approach to the management of cardiogenic shock. Heart Failure. 2020;8(11):879–91.PubMed
4.
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341(9):625–34.PubMedCrossRef
5.
Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–32.PubMedCrossRef
6.
Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232–68.PubMed
7.
Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019;40(32):2671–83.PubMedCrossRef
8.
Zeymer U, Bueno H, Granger C, Hochman J, Huber K, Lettino M, et al. ACCA-position paper for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2020;9:183–97.PubMedCrossRef
9.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Boehm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.PubMedCrossRef
10.
Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020;396(10245):199–212.PubMedCrossRef
11.
Hiratzka L, Bakris G, Beckman J, O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:485–510 (Journal of the American College of Cardiology. 2013;62(11)).CrossRef
12.
Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial REVASCULARIZATION. Eur Heart J. 2019;40(2):87–165.PubMedCrossRef
13.
Dudzinsk JE, Gnall E, Kowey PR. A review of percutaneous mechanical support devices and strategies. Rev Cardiovasc Med. 2018;19(1):21–6.PubMedCrossRef
14.
Kantrowitz A, Tjønneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113–8.PubMedCrossRef
15.
Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–96.PubMedCrossRef
16.
Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382(9905):1638–45.PubMedCrossRef
17.
Thiele H, Zeymer U, Thelemann N, Neumann F, Hausleiter J, Abdel-Wahab M, et al. IABP-SHOCK II Trial Investigators intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial. Circulation. 2019;139:395–403.PubMedCrossRef
18.
Kovack PJ, Rasak MA, Bates ER, Ohman EM, Stomel RJ. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol. 1997;29(7):1454–8.PubMedCrossRef
19.
Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2000;36(3S1):1123–9.PubMedCrossRef
20.
Gu J, Hu W, Xiao H, Feng X, Chen Y, Zhang D. Intra-aortic balloon pump improves clinical prognosis and attenuates C-reactive protein level in acute STEMI complicated by cardiogenic shock. Cardiology. 2010;117(1):75–80.PubMedCrossRef
21.
Ahmad Y, Sen S, Shun-Shin MJ, Ouyang J, Finegold JA, Al-Lamee RK, et al. Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis. JAMA Intern Med. 2015;175(6):931–9.PubMedCrossRef
22.
Chahdi HO, Berbach L, Boivin-Proulx L-A, Hillani A, Noiseux N, Matteau A, et al. Percutaneous mechanical circulatory support in post-myocardial infarction cardiogenic shock: a systematic review and meta-analysis. Can J Cardiol. 2022;38(10):1525–38.CrossRef
23.
Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141(6):933–9.PubMedCrossRef
24.
Hawranek M, Gierlotka M, Pres D, Zembala M, Gąsior M. Nonroutine use of intra-aortic balloon pump in cardiogenic shock complicating myocardial infarction with successful and unsuccessful primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2018;11(18):1885–93.PubMedCrossRef
25.
Huang C-C, Liao P-C, Ke S-R, Hsu J-C. TCT-21 door-to-ECMO before door-to-balloon? Early implementation of ECMO might improve the survival of patients with STEMI complicated by refractory cardiogenic shock. J the Am Coll Cardiol. 2016;68(18S):B9-B.CrossRef
26.
den Uil CA, Van Mieghem NM, Bastos M, Jewbali LS, Lenzen MJ, Engstrom AE, et al. Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial. EuroIntervention. 2019;15(7):586–93.CrossRef
27.
Malick W, Fried JA, Masoumi A, Nair A, Zuver A, Huang A, et al. Comparison of the hemodynamic response to intra-aortic balloon counterpulsation in patients with cardiogenic shock resulting from acute myocardial infarction versus acute decompensated heart failure. Am J Cardiol. 2019;124(12):1947–53.PubMedPubMedCentralCrossRef
28.
Estep JD, Cordero-Reyes AM, Bhimaraj A, Trachtenberg B, Khalil N, Loebe M, et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Failure. 2013;1(5):382–8.PubMedCrossRef
29.
Bhimaraj A, Agrawal T, Duran A, Tamimi O, Amione-Guerra J, Trachtenberg B, et al. Percutaneous left axillary artery placement of intra-aortic balloon pump in advanced heart failure patients. Heart Failure. 2020;8(4):313–23.PubMed
30.
Tanaka A, Tuladhar SM, Onsager D, Asfaw Z, Ota T, Juricek C, et al. The subclavian intraaortic balloon pump: a compelling bridge device for advanced heart failure. Ann Thorac Surg. 2015;100(6):2151–8.PubMedCrossRef
31.
Choi KH, Yang JH, Park TK, Lee JM, Song YB, Hahn J-Y, et al. Differential prognostic implications of vasoactive inotropic score for patients with acute myocardial infarction complicated by cardiogenic shock according to use of mechanical circulatory support. Crit Care Med. 2021;49(5):770–80.PubMedCrossRef
32.
Brunner S, Guenther SP, Lackermair K, Peterss S, Orban M, Boulesteix A-L, et al. Extracorporeal life support in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2019;73(18):2355–7.PubMedCrossRef
33.
Lackermair K, Brunner S, Orban M, Peterss S, Orban M, Theiss HD, et al. Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-Shock study. Clin Res Cardiol. 2021;110:1412–20.PubMedCrossRef
34.
Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. 2023;147(6):454–64.PubMedCrossRef
35.
36.
Whiteside HL, Hillerson D, Abdel-Latif A, Gupta VA. Prognostic implication of pre-cannulation cardiac arrest in patients undergoing extracorporeal membrane oxygenation for the management of cardiogenic shock. J Intensive Care Med. 2023;38(2):202–7.PubMedCrossRef
37.
Kittleson MM, Patel JK, Moriguchi JD, Kawano M, Davis S, Hage A, et al. Heart transplant recipients supported with extracorporeal membrane oxygenation: outcomes from a single-center experience. J Heart Lung Transplant. 2011;30(11):1250–6.PubMedCrossRef
38.
Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström A, Lagrand WK, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med. 2016;42:1922–34.PubMedPubMedCentralCrossRef
39.
Vallabhajosyula S, Dunlay SM, Barsness GW, Miller PE, Cheungpasitporn W, Stulak JM, et al. Sex disparities in the use and outcomes of temporary mechanical circulatory support for acute myocardial infarction-cardiogenic shock. CJC open. 2020;2(6):462–72.PubMedPubMedCentralCrossRef
40.
Vojjini R, Patlolla SH, Cheungpasitporn W, Kumar A, Sundaragiri PR, Doshi RP, et al. Racial disparities in the utilization and outcomes of temporary mechanical circulatory support for acute myocardial infarction-cardiogenic shock. J Clin Med. 2021;10(7):1459.PubMedPubMedCentralCrossRef
41.
Lauridsen MD, Josiassen J, Schmidt M, Butt JH, Østergaard L, Schou M, et al. Prognosis of myocardial infarction-related cardiogenic shock according to preadmission out-of-hospital cardiac arrest. Resuscitation. 2021;162:135–42.PubMedCrossRef
42.
Takahashi K, Kubo S, Ikuta A, Osakada K, Takamatsu M, Taguchi Y, et al. Incidence, predictors, and clinical outcomes of mechanical circulatory support-related complications in patients with cardiogenic shock. J Cardiol. 2022;79(2):163–9.PubMedCrossRef
43.
Freund A, Jobs A, Lurz P, Feistritzer H-J, de Waha-Thiele S, Meyer-Saraei R, et al. Frequency and impact of bleeding on outcome in patients with cardiogenic shock. Cardiovasc Interv. 2020;13(10):1182–93.
44.
Aubron C, Cheng AC, Pilcher D, Leong T, Magrin G, Cooper DJ, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study. Crit Care. 2013;17:1–12.CrossRef
45.
Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2014;97(2):610–6.PubMedCrossRef
46.
Jia D, Yang IX, Ling RR, Syn N, Poon WH, Murughan K, et al. Vascular complications of extracorporeal membrane oxygenation: a systematic review and meta-regression analysis. Crit Care Med. 2020;48(12):e1269–77.PubMedCrossRef
47.
Ferguson JJ, Cohen M, Freedman RJ, Stone GW, Miller MF, Joseph DL, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38(5):1456–62.PubMedCrossRef
48.
Bréchot N, Demondion P, Santi F, Lebreton G, Pham T, Dalakidis A, et al. Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation. Eur Heart J Acute Cardiovasc Care. 2018;7(1):62–9.PubMedCrossRef
49.
Mao C-T, Wang J-L, Chen D-Y, Tsai M-L, Lin Y-S, Cherng W-J, et al. Benefits of intraaortic balloon support for myocardial infarction patients in severe cardiogenic shock undergoing coronary revascularization. PLoS ONE. 2016;11(8): e0160070.PubMedPubMedCentralCrossRef
50.
Timóteo AT, Nogueira MA, Rosa SA, Belo A, Ferreira RC, Investigators P. Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: evidence from the Portuguese nationwide registry. Eur Heart J Acute Cardiovasc Care. 2016;5(7):23–31.PubMedCrossRef
51.
Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2020;323(8):734–45.PubMedPubMedCentralCrossRef
52.
Chu S, Sun P, Zhang Y, Li J, Liu L, Shi Y, et al. Intra-aortic balloon pump on in-hospital outcomes of cardiogenic shock: findings from a nationwide registry. China ESC Heart Failure. 2021;8(4):3286–94.PubMedCrossRef
53.
de Jong MM, Lorusso R, Al Awami F, Matteuci F, Parise O, Lozekoot P, et al. Vascular complications following intra-aortic balloon pump implantation: an updated review. Perfusion. 2018;33(2):96–104.PubMedCrossRef
54.
Varshney AS, Berg DD, Zhou G, Sinnenberg L, Hirji S, DeFilippis EM, et al. Bridging strategies and cardiac replacement outcomes in patients with acute decompensated heart failure-related cardiogenic shock. European J Heart Failure. 2023;25(3):425–35.CrossRef
55.
Burkhoff D, Sayer G, Doshi D, Uriel N. Hemodynamics of mechanical circulatory support. J Am Coll Cardiol. 2015;66(23):2663–74.PubMedCrossRef
56.
Lüsebrink E, Binzenhöfer L, Kellnar A, Müller C, Scherer C, Schrage B, et al. Venting during venoarterial extracorporeal membrane oxygenation. Clin Res Cardiol. 2023;112(4):464–505.PubMedCrossRef
57.
Eliet J, Gaudard P, Zeroual N, Rouvière P, Albat B, Mourad M, et al. Effect of Impella during veno-arterial extracorporeal membrane oxygenation on pulmonary artery flow as assessed by end-tidal carbon dioxide. ASAIO J. 2018;64(4):502–7.PubMedCrossRef
58.
Donker DW, Brodie D, Henriques JP, Broomé M. Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions. Perfusion. 2019;34(2):98–105.PubMedCrossRef
59.
Baldetti L, Gramegna M, Beneduce A, Melillo F, Moroni F, Calvo F, et al. Strategies of left ventricular unloading during VA-ECMO support: a network meta-analysis. Int J Cardiol. 2020;312:16–21.PubMedCrossRef
60.
Freund A, Desch S, Pöss J, Sulimov D, Sandri M, Majunke N, et al. Extracorporeal membrane oxygenation in infarct-related cardiogenic shock. J Clin Med. 2022;11(5):1256.PubMedPubMedCentralCrossRef
61.
Tsao N-W, Shih C-M, Yeh J-S, Kao Y-T, Hsieh M-H, Ou K-L, et al. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock. J Crit Care. 2012;27(5):530.e1-530.e11.PubMedCrossRef
62.
Romeo F, Acconcia MC, Sergi D, Romeo A, Francioni S, Chiarotti F, et al. Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: review, meta-analysis. World J Cardiol. 2016;8(1):98.PubMedPubMedCentralCrossRef
63.
Overtchouk P, Pascal J, Lebreton G, Hulot J-S, Luyt C-E, Combes A, et al. Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. EuroInterv J EuroPCR Collab Work Group Interv Cardiol Eur Soc Cardiol. 2018;13(18):e2160–8.
64.
Russo JJ, Aleksova N, Pitcher I, Couture E, Parlow S, Faraz M, et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol. 2019;73(6):654–62.PubMedCrossRef
65.
Li Y, Yan S, Gao S, Liu M, Lou S, Liu G, et al. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2019;55(3):395–404.PubMedCrossRef
66.
Vallabhajosyula S, O’Horo JC, Antharam P, Ananthaneni S, Vallabhajosyula S, Stulak JM, et al. Concomitant intra-aortic balloon pump use in cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2018;11(9):e006930.PubMedCrossRef
67.
Zeng P, Yang C, Chen J, Fan Z, Cai W, Huang Y, et al. Comparison of the efficacy of ECMO with or without IABP in patients with cardiogenic shock: a meta-analysis. Front Cardiovasc Med. 2022;9:917610.PubMedPubMedCentralCrossRef
68.
Benenati S, Toma M, Canale C, Vergallo R, Bona RD, Ricci D, et al. Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis. Heart Fail Rev. 2022;27(3):927–34.PubMedCrossRef
69.
Aso S, Matsui H, Fushimi K, Yasunaga H. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database. Crit Care Med. 2016;44(11):1974–9.PubMedCrossRef
70.
Wang L, Xing Z. Short-term outcomes of intra-aortic balloon pump combined with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Artif Organs. 2019;43(6):561–8.PubMedCrossRef
71.
Duan J, Shi Y, Luo G, Peng Y, Duan B, Zhang Z. Short-term efficacy and safety of different mechanical hemodynamic support devices for cardiogenic shock or high-risk Pci: a network meta-analysis of thirty-seven trials. Shock. 2021;55(1):5–13.PubMedCrossRef
72.
Meertens MM, Tichelbäcker T, Macherey-Meyer S, Heyne S, Braumann S, Nießen SF, et al. Meta-analysis of extracorporeal membrane oxygenation in combination with intra-aortic balloon pump vs. extracorporeal membrane oxygenation only in patients with cardiogenic shock due to acute myocardial infarction. Front Cardiovasc Med. 2022;9:1104357.PubMedCrossRef
73.
Nishi T, Ishii M, Tsujita K, Okamoto H, Koto S, Nakai M, et al. Outcomes of venoarterial extracorporeal membrane oxygenation plus intra-aortic balloon pumping for treatment of acute myocardial infarction complicated by cardiogenic shock. J Am Heart Assoc. 2022;11(7): e023713.PubMedPubMedCentralCrossRef
74.
Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study. Circulation. 2020;142(22):2095–106.PubMedPubMedCentralCrossRef
75.
Tonna J, Selzman C, Bartos J, Presson A, Jo Y, Becker LB, et al. Critical care management, hospital case volume, and survival after extracorporeal cardiopulmonary resuscitation. Circulation. 2020;142(Suppl_4):A117-A.CrossRef
76.
Grandin EW, Nunez JI, Willar B, Kennedy K, Rycus P, Tonna JE, et al. Mechanical left ventricular unloading in patients undergoing venoarterial extracorporeal membrane oxygenation. J Am Coll Cardiol. 2022;79(13):1239–50.PubMedPubMedCentralCrossRef
77.
Au S-Y, Fong K-M, Tsang C-FS, Chan K-CA, Wong CY, Ng W-YG, et al. Veno-arterial extracorporeal membrane oxygenation with concomitant Impella versus concomitant intra-aortic-balloon-pump for cardiogenic shock. Perfusion. 2023;38(1):51–7.PubMedCrossRef
78.
Char S, Fried J, Melehy A, Mehta S, Ning Y, Kurlansky P, et al. Clinical efficacy of direct or indirect left ventricular unloading during venoarterial extracorporeal membrane oxygenation for primary cardiogenic shock. J Thorac Cardiovasc Surg. 2023;165(2):699-707.e5.PubMedCrossRef
79.
Gass A, Palaniswamy C, Aronow WS, Kolte D, Khera S, Ahmad H, et al. Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. Cardiology. 2014;129(3):137–43.PubMedCrossRef
80.
Petroni T, Harrois A, Amour J, Lebreton G, Brechot N, Tanaka S, et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Crit Care Med. 2014;42(9):2075–82.PubMedCrossRef
81.
Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol. 2015;65(19):e7–26.PubMedCrossRef
82.
Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022;79(9):933–46.PubMedCrossRef
83.
Acosta ME, Belkin MN, Nathan S. Selection of percutaneous mechanical circulatory support in cardiogenic shock: patient-specific considerations and insights from contemporary clinical data. Curr Opin Cardiol. 2023;38(1):47–53.PubMedCrossRef
Metadaten
Titel
Perspectives and Considerations of IABP in the Era of ECMO for Cardiogenic Shock
verfasst von
Zelin Chen
Yuping Gao
Yuanyuan Lin
Publikationsdatum
18.07.2023
Verlag
Springer Healthcare
Erschienen in
Advances in Therapy / Ausgabe 10/2023
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-023-02598-8

Weitere Artikel der Ausgabe 10/2023

Advances in Therapy 10/2023 Zur Ausgabe

Correction

Correction to: Effect of Nicorandil, Diltiazem, or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts—A Pilot Randomized Controlled Trial (ASRAB-Pilot): Rationale and Study Protocol

Original Research

The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)

Correction

Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

Original Research

Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease

Review

Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022

Original Research

The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise